The effect of surface roughness on RAW 264.7 macrophage phenotype

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 9, 2013, Pages 2679-2688

  Barth, Katrin A ^a   Waterfield, J Douglas ^a   Brunette, Donald M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

chemokines; macrophage; macrophage activation; MCP 1 (CCL2); surface roughness

Indexed keywords

ANTIBODY ARRAYS; CHEMOKINES; FOREIGN BODY GIANT CELLS; IMPLANTED DEVICE; MACROPHAGE ACTIVATION; MCP-1 (CCL2); POSSIBLE MECHANISMS; RAW 264.7 MACROPHAGES;

BIOLOGICAL MATERIALS; BIOMATERIALS; BONE; PEPTIDES; PHYSIOLOGY; POLYMERASE CHAIN REACTION; REPAIR; SURFACE ROUGHNESS;

MACROPHAGES;

GAMMA INTERFERON; INTERLEUKIN 4; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ARTICLE; CELL SURFACE; ENZYME LINKED IMMUNOSORBENT ASSAY; MACROPHAGE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; SURFACE PROPERTY;

CHEMOKINES; MACROPHAGE; MACROPHAGE ACTIVATION; MCP-1 (CCL2); SURFACE ROUGHNESS;

ANIMALS; ARGINASE; CELL LINE; CHEMOKINES; CYTOKINES; DENTAL ETCHING; DENTAL IMPLANTS; DENTAL MATERIALS; GENE EXPRESSION; MACROPHAGES; MATERIALS TESTING; MICE; NITRIC OXIDE SYNTHASE TYPE II; OSSEOINTEGRATION; PHENOTYPE; SURFACE PROPERTIES;

EID: 84880591292     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34562     Document Type: Article

References (49)

1. Mendonça G, Mendonça DBS, Aragão FJL, Cooper LF,. Advancing dental implant surface technology-From micron- to nanotopography. Biomaterials 2008; 29: 3822-3835.
2. Cooper LF,. Biologic determinants of bone formation for osseointegration: Clues for future clinical improvements. J Prosthet Dent 1998; 80: 439-449.
3. Salthouse TN,. Some aspects of macrophage behavior at the implant interface. J Biomed Mater Res 1984; 18: 395-401.
4. Rich A, Harris AK,. Anomalous preferences of cultured macrophages for hydrophobic and roughened substrata. J Cell Sci 1981; 50: 1-7.
5. Mosser DM,. The many faces of macrophage activation. J Leukoc Biol 2003; 73: 209-212.
6. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M,. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686.
7. Martinez FO, Helming L, Gordon S,. Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-483.
8. Mosser DM, Edwards JP,. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
9. Song E, Ouyang N, Hörbelt M, Antus B, Wang M, Exton MS,. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol 2000; 204: 19-28.
10. Thomsen P, Gretzer C,. Macrophage interactions with modified material surfaces. Curr Opin Solid State Mater Sci 2001; 5: 163-176.
11. Takebe J, Champagne CM, Offenbacher S, Ishibashi K, Cooper LF,. Titanium surface topography alters cell shape and modulates bone morphogenetic protein 2 expression in the J774A.1 macrophage cell line. J Biomed Mater Res A 2003; 64: 207-216.
12. Refai AK, Textor M, Brunette DM, Waterfield JD,. Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines. J Biomed Mater Res A 2004; 70: 194-205.
13. Tan KS, Qian L, Rosado R, Flood PM, Cooper LF,. The role of titanium surface topography on J774A.1 macrophage inflammatory cytokines and nitric oxide production. Biomaterials 2006; 27: 5170-5177.
14. Paul NE, Skazik C, Harwardt M, Bartneck M, Denecke B, Klee D, Salber J, Zwadlo-Klarwasser G,. Topographical control of human macrophages by a regularly microstructured polyvinylidene fluoride surface. Biomaterials 2008; 29: 4056-4064.
15. Chen S, Jones JA, Xu Y, Low H-Y, Anderson JM, Leong KW,. Characterization of topographical effects on macrophage behavior in a foreign body response model. Biomaterials 2010; 31: 3479-3491.
16. Bota PCS, Collie AMB, Puolakkainen P, Vernon RB, Sage EH, Ratner BD, Stayton PS,. Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro. J Biomed Mater Res A 2010; 95: 649-657.
17. Bartneck M, Schulte VA, Paul NE, Diez M, Lensen MC, Zwadlo-Klarwasser G,. Induction of specific macrophage subtypes by defined micro-patterned structures. Acta Biomater 2010; 6: 3864-3872.
18. Saino E, Focarete ML, Gualandi C, Emanuele E, Cornaglia AI, Imbriani M, Visai L,. Effect of electrospun fiber diameter and alignment on macrophage activation and secretion of proinflammatory cytokines and chemokines. Biomacromolecules 2011; 12: 1900-1911.
19. Chehroudi B, Ghrebi S, Murakami H, Waterfield JD, Owen G, Brunette DM,. Bone formation on rough, but not polished, subcutaneously implanted Ti surfaces is preceded by macrophage accumulation. J Biomed Mater Res A 2010; 93: 724-737.
20. Wennerberg A, Albrektsson T, Andersson B,. An animal study of c.p. titanium screws with different surface topographies. J Mater Sci Mater Med 1995; 6: 302-309.
21. Madden LR, Mortisen DJ, Sussman EM, Dupras SK, Fugate JA, Cuy JL, Hauch KD, Laflamme MA, Murry CE, Ratner BD,. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci USA 2010; 107: 15211-15216.
22. Anselme K, Bigerelle M,. Role of materials surface topography on mammalian cell response. Int Mater Rev 2011; 56: 243-266.
23. Bettinger CJ, Langer R, Borenstein JT,. Engineering substrate topography at the micro- and nanoscale to control cell function. Angew Chem Int Ed 2009; 48: 5406-5415.
24. Chehroudi B, Gould T, Brunette D,. Effects of a grooved epoxy substratum on epithelial cell behavior in vitro and in vivo. J Biomed Mater Res 1988; 22: 459-473.
25. Wieland M, Chehroudi B, Textor M, Brunette DM,. Use of Ti-coated replicas to investigate the effects on fibroblast shape of surfaces with varying roughness and constant chemical composition. J Biomed Mater Res 2002; 60: 434-444.
26. Schuler M, Kunzler TP, De Wild M, Sprecher CM, Trentin D, Brunette DM, Textor M, Tosatti SGP,. Fabrication of TiO2-coated epoxy replicas with identical dual-type surface topographies used in cell culture assays. J Biomed Mater Res A 2009; 88: 12-22.
27. Salitsky A,. The Raw 264.7 Cell Line: A Valid Candidate for Studying Macrophage Activation. Philadelphia, Pa: Hahnemann University, Department of Microbiology and Immunology; 1983.
28. Waterfield JD, Ali TA, Nahid F, Kusano K, Brunette DM,. The effect of surface topography on early NFκB signaling in macrophages. J Biomed Mater Res A 2010; 95: 837-847.
29. Ghrebi S, Hamilton DW, Waterfield JD, Brunette DM,. The effect of surface topography on cell shape and early ERK1/2 signaling in macrophages; linkage with FAK and Src. J Biomed Mat Res A 2013;in press.
30. Erdely A, Kepka-Lenhart D, Clark M, Zeidler-Erdely P, Poljakovic M, Calhoun WJ, Morris SM,. Inhibition of phosphodiesterase 4 amplifies cytokine-dependent induction of arginase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006; 290: L534-L539.
31. MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, Nilsson UJ, Haslett C, Forbes SJ, Sethi T,. Regulation of alternative macrophage activation by galectin-3. J Immunol 2008; 180: 2650-2658.
32. -ΔΔCT method. Methods 2001; 25: 402-408.
33. Jabbar SA, Twentyman PR, Watson JV,. The MTT assay underestimates the growth inhibitory effects of interferons. Br J Cancer 1989; 60: 523-528.
34. Menzies FM, Henriquez FL, Alexander J, Roberts CW,. Sequential expression of macrophage anti-microbial/inflammatory and wound healing markers following innate, alternative and classical activation. Clin Exp Immunol 2010; 160: 369-379.
35. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW, Pearce EJ, Wynn TA,. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: Granulomatous pathology is shaped by the pattern of L -arginine metabolism. J Immunol 2001; 167: 6533-6544.
36. Stout RD, Suttles J,. Functional plasticity of macrophages: Reversible adaptation to changing microenvironments. J Leukoc Biol 2004; 76: 509-513.
37. Chamberlain LM, Godek ML, Gonzalez-Juarrero M, Grainger DW,. Phenotypic non-equivalence of murine (monocyte-) macrophage cells in biomaterial and inflammatory models. J Biomed Mater Res A 2009; 88: 858-871.
38. Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ,. Aging and innate immune cells. J Leukoc Biol 2004; 76: 291-299.
39. Munder M, Eichmann K, Morán JM, Centeno F, Soler G, Modolell M,. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 1999; 163: 3771-3777.
40. Edwards JP, Zhang X, Frauwirth KA, Mosser DM,. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 2006; 80: 1298-1307.
41. Jones JA, Chang DT, Meyerson H, Colton E, Kwon IK, Matsuda T, Anderson JM,. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J Biomed Mater Res A 2007; 83: 585-596.
42. Vannier E, Miller LC, Dinarello CA,. Coordinated antiinflammatory effects of interleukin 4: Interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1992; 89: 4076-4080.
43. Gabay C, Porter B, Fantuzzi G, Arend W,. Mouse IL-1 receptor antagonist isoforms: Complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo. J Immunol 1997; 159: 5905-5913.
44. DiPietro LA, Burdick M, Low QE, Kunkel SL, Strieter RM,. MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest 1998; 101: 1693-1698.
45. Low QE, Drugea IA, Duffner LA, Quinn DG, Cook DN, Rollins BJ, Kovacs EJ, DiPietro LA,. Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. Am J Pathol 2001; 159: 457-463.
46. Chensue S, Warmington K, Ruth J, Sanghi P, Lincoln P, Kunkel S,. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: Relationship to local inflammation, Th cell expression, and IL-12 production. J Immunol 1996; 157: 4602-4608.
47. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ,. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000; 404: 407-411.
48. Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G,. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 1995; 182: 155-162.
49. Gillitzer R, Goebeler M,. Chemokines in cutaneous wound healing. J Leukoc Biol 2001; 69: 513-521.